SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-16-004689
Filing Date
2016-05-23
Accepted
2016-05-23 16:02:20
Documents
70
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q biostar10q033116.htm 10-Q 779348
2 EX-31.1 ex31-1.htm EX-31.1 13806
3 EX-31.2 ex31-2.htm EX-31.2 13890
4 EX-32.1 ex32-1.htm EX-32.1 5678
5 EX-32.2 ex32-2.htm EX-32.2 5416
  Complete submission text file 0001185185-16-004689.txt   4560712

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bspm-20160331.xml EX-101.INS 1009239
7 XBRL TAXONOMY EXTENSION SCHEMA bspm-20160331.xsd EX-101.SCH 50727
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bspm-20160331_cal.xml EX-101.CAL 34209
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bspm-20160331_def.xml EX-101.DEF 232997
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bspm-20160331_lab.xml EX-101.LAB 293293
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bspm-20160331_pre.xml EX-101.PRE 235884
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 161669017
SIC: 2834 Pharmaceutical Preparations